Filed: 2/17/2026ACC: 0001388325-26-000007
📋 What this filing means
NOVO HOLDINGS A/S filed this quarterly 13F‑HR report disclosing 24 equity positions with a total reported market value of $1.29B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
24
Positions
$1.29B
Total AUM (reported)
39.70M
Total Shares
Allocation by class
COM$851.05M66.1%
CL A LTD VT SH$160.44M12.5%
N Y REGISTRY SHS$121.91M9.5%
COM NEW$59.32M4.6%
SPONSORED ADS$58.05M4.5%
COM PAR $.01$34.81M2.7%
CLASS A COM$2.10M0.2%
Portfolio Concentration
Top 3$415.11M32.2%
4–10$502.99M39.1%
11–25$369.58M28.7%
Top 3 weight
32.2%
Top 10 weight
71.3%
Voting Authority Distribution
Total shares with voting rights: 39.70M
Sole
Full voting authority
39.70M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole24
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings24
Rows:
BROOKFIELD CORP
SOLEShares3.50M
TypeSH
Market value$160.44M
12.46%
Sole
3.50M
Shared
0.00
None
0.00
EDGEWISE THERAPEUTICS INC
SOLEShares5.35M
TypeSH
Market value$132.76M
10.31%
Sole
5.35M
Shared
0.00
None
0.00
ASML HOLDING N V
SOLEShares113.95K
TypeSH
Market value$121.91M
9.47%
Sole
113.95K
Shared
0.00
None
0.00
MIRUM PHARMACEUTICALS INC
SOLEShares1.26M
TypeSH
Market value$99.85M
7.75%
Sole
1.26M
Shared
0.00
None
0.00
SALESFORCE INC
SOLEShares330.19K
TypeSH
Market value$87.47M
6.79%
Sole
330.19K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares1.63M
TypeSH
Market value$75.64M
5.87%
Sole
1.63M
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares2.38M
TypeSH
Market value$74.07M
5.75%
Sole
2.38M
Shared
0.00
None
0.00
MAPLIGHT THERAPEUTICS INC
SOLEShares3.69M
TypeSH
Market value$64.76M
5.03%
Sole
3.69M
Shared
0.00
None
0.00
ZENAS BIOPHARMA INC
SOLEShares1.45M
TypeSH
Market value$52.65M
4.09%
Sole
1.45M
Shared
0.00
None
0.00
PHARVARIS N V
SOLEShares1.75M
TypeSH
Market value$48.56M
3.77%
Sole
1.75M
Shared
0.00
None
0.00
APOGEE THERAPEUTICS INC
SOLEShares570K
TypeSH
Market value$43.02M
3.34%
Sole
570K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares916.16K
TypeSH
Market value$42.27M
3.28%
Sole
916.16K
Shared
0.00
None
0.00
BIOMARIN PHARMACEUTICAL INC
SOLEShares660K
TypeSH
Market value$39.22M
3.05%
Sole
660K
Shared
0.00
None
0.00
ARRIVENT BIOPHARMA INC
SOLEShares1.94M
TypeSH
Market value$39.08M
3.03%
Sole
1.94M
Shared
0.00
None
0.00
ALIBABA GROUP HLDG LTD
SOLEShares257.33K
TypeSH
Market value$37.72M
2.93%
Sole
257.33K
Shared
0.00
None
0.00
INSMED INC
SOLEShares200K
TypeSH
Market value$34.81M
2.70%
Sole
200K
Shared
0.00
None
0.00
CELLDEX THERAPEUTICS INC NEW
SOLEShares1.20M
TypeSH
Market value$32.59M
2.53%
Sole
1.20M
Shared
0.00
None
0.00
4D MOLECULAR THERAPEUTICS IN
SOLEShares3.65M
TypeSH
Market value$27.38M
2.13%
Sole
3.65M
Shared
0.00
None
0.00
BRIDGEBIO ONCOLOGY THERAPEUT
SOLEShares1.96M
TypeSH
Market value$24.56M
1.91%
Sole
1.96M
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares1.48M
TypeSH
Market value$22.79M
1.77%
Sole
1.48M
Shared
0.00
None
0.00
VALNEVA SE
SOLEShares2.31M
TypeSH
Market value$20.33M
1.58%
Sole
2.31M
Shared
0.00
None
0.00
LANZATECH GLOBAL INC
SOLEShares158.15K
TypeSH
Market value$2.18M
0.17%
Sole
158.15K
Shared
0.00
None
0.00
MARQETA INC
SOLEShares441.56K
TypeSH
Market value$2.10M
0.16%
Sole
441.56K
Shared
0.00
None
0.00
IO BIOTECH INC
SOLEShares2.51M
TypeSH
Market value$1.53M
0.12%
Sole
2.51M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BROOKFIELD CORPSOLE | CL A LTD VT SH | 3.50M | SH | $160.44M 12.46% | 3.50M | 0.00 | 0.00 |
EDGEWISE THERAPEUTICS INCSOLE | COM | 5.35M | SH | $132.76M 10.31% | 5.35M | 0.00 | 0.00 |
ASML HOLDING N VSOLE | N Y REGISTRY SHS | 113.95K | SH | $121.91M 9.47% | 113.95K | 0.00 | 0.00 |
MIRUM PHARMACEUTICALS INCSOLE | COM | 1.26M | SH | $99.85M 7.75% | 1.26M | 0.00 | 0.00 |
SALESFORCE INCSOLE | COM | 330.19K | SH | $87.47M 6.79% | 330.19K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 1.63M | SH | $75.64M 5.87% | 1.63M | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 2.38M | SH | $74.07M 5.75% | 2.38M | 0.00 | 0.00 |
MAPLIGHT THERAPEUTICS INCSOLE | COM | 3.69M | SH | $64.76M 5.03% | 3.69M | 0.00 | 0.00 |
ZENAS BIOPHARMA INCSOLE | COM | 1.45M | SH | $52.65M 4.09% | 1.45M | 0.00 | 0.00 |
PHARVARIS N VSOLE | COM | 1.75M | SH | $48.56M 3.77% | 1.75M | 0.00 | 0.00 |
APOGEE THERAPEUTICS INCSOLE | COM | 570K | SH | $43.02M 3.34% | 570K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 916.16K | SH | $42.27M 3.28% | 916.16K | 0.00 | 0.00 |
BIOMARIN PHARMACEUTICAL INCSOLE | COM | 660K | SH | $39.22M 3.05% | 660K | 0.00 | 0.00 |
ARRIVENT BIOPHARMA INCSOLE | COM | 1.94M | SH | $39.08M 3.03% | 1.94M | 0.00 | 0.00 |
ALIBABA GROUP HLDG LTDSOLE | SPONSORED ADS | 257.33K | SH | $37.72M 2.93% | 257.33K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 200K | SH | $34.81M 2.70% | 200K | 0.00 | 0.00 |
CELLDEX THERAPEUTICS INC NEWSOLE | COM NEW | 1.20M | SH | $32.59M 2.53% | 1.20M | 0.00 | 0.00 |
4D MOLECULAR THERAPEUTICS INSOLE | COM | 3.65M | SH | $27.38M 2.13% | 3.65M | 0.00 | 0.00 |
BRIDGEBIO ONCOLOGY THERAPEUTSOLE | COM NEW | 1.96M | SH | $24.56M 1.91% | 1.96M | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 1.48M | SH | $22.79M 1.77% | 1.48M | 0.00 | 0.00 |
VALNEVA SESOLE | SPONSORED ADS | 2.31M | SH | $20.33M 1.58% | 2.31M | 0.00 | 0.00 |
LANZATECH GLOBAL INCSOLE | COM NEW | 158.15K | SH | $2.18M 0.17% | 158.15K | 0.00 | 0.00 |
MARQETA INCSOLE | CLASS A COM | 441.56K | SH | $2.10M 0.16% | 441.56K | 0.00 | 0.00 |
IO BIOTECH INCSOLE | COM | 2.51M | SH | $1.53M 0.12% | 2.51M | 0.00 | 0.00 |